Microparticles: New Protagonists in Pericellular and Intravascular Proteolysis

 

 Buy Article Permissions and Reprints

Abstract

Microparticles (MPs) are small vesicles resulting from the shedding of cellular membrane during activation or apoptosis processes. Beyond their well-described procoagulant property, accumulating data show that specific endothelial cell-, leukocyte-, tumor-derived MPs bind plasminogen and vectorize plasminogen activators, leading to an efficient plasmin generation and matrix metalloproteinases activation. This review focuses on the molecular equipment of MPs subpopulations that identify MPs as efficient support for plasmin generation and the potential consequences of this new function. By the combined facts that MPs may disseminate, concentrate active proteolytic molecules and represent a protective environment against soluble inhibitors, MPs behave as an efficient catalytic surface involved in vascular and matrix proteolysis–related biological processes. The existence of this proteolytic MPs in the circulation or in body fluids raises the question about the physiological relevance of this activity. Consequences are suggested in many biological processes such as fibrinolysis, cell survival, matrix remodeling, angiogenesis, and tumor metastasis. However, further studies will be necessary to determine the extent in which in vivo MPs contribute to these pathophysiological mechanisms and how this circulating property of MPs may represent a new biomarker in specific clinical situations.

• References

• 1 Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73 (10) 1907-1920
  CrossrefPubMedGoogle Scholar
• 2 Hristov M, Erl W, Linder S, Weber PC. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 2004; 104 (9) 2761-2766
  CrossrefPubMedGoogle Scholar
• 3 Berda-Haddad Y, Robert S, Salers P , et al. Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α. Proc Natl Acad Sci U S A 2011; 108 (51) 20684-20689
  CrossrefPubMedGoogle Scholar
• 4 Morel O, Toti F, Jesel L, Freyssinet JM. Mechanisms of microparticle generation: on the trail of the mitochondrion!. Semin Thromb Hemost 2010; 36 (8) 833-844
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Hunter MP, Ismail N, Zhang X , et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008; 3 (11) e3694
  CrossrefPubMedGoogle Scholar
• 6 Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78 (9) 838-848
  CrossrefPubMedGoogle Scholar
• 7 Owens III AP, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108 (10) 1284-1297
  CrossrefPubMedGoogle Scholar
• 8 Broze Jr GJ. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74 (1) 90-93
  PubMedGoogle Scholar
• 9 Kushak RI, Nestoridi E, Lambert J, Selig MK, Ingelfinger JR, Grabowski EF. Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res 2005; 116 (5) 409-419
  CrossrefPubMedGoogle Scholar
• 10 Aharon A, Katzenell S, Tamari T, Brenner B. Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost 2009; 7 (6) 1047-1050
  CrossrefPubMedGoogle Scholar
• 11 Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schömig A, Ott I. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005; 93 (1) 35-39
  PubMedGoogle Scholar
• 12 Tsimerman G, Roguin A, Bachar A, Melamed E, Brenner B, Aharon A. Involvement of microparticles in diabetic vascular complications. Thromb Haemost 2011; 106 (2) 310-321
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Pérez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica 2009; 94 (3) 387-394
  CrossrefPubMedGoogle Scholar
• 14 Pérez-Casal M, Downey C, Fukudome K, Marx G, Toh CH. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood 2005; 105 (4) 1515-1522
  CrossrefPubMedGoogle Scholar
• 15 Rijken DC, Lijnen HR. New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost 2009; 7 (1) 4-13
  CrossrefPubMedGoogle Scholar
• 16 Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost 1980; 43 (2) 77-89
  PubMedGoogle Scholar
• 17 Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30 (6) 1682-1691
  CrossrefPubMedGoogle Scholar
• 18 Hawley SB, Tamura T, Miles LA. Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. J Biol Chem 2001; 276 (1) 179-186
  PubMedGoogle Scholar
• 19 Pluskota E, Soloviev DA, Bdeir K, Cines DB, Plow EF. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J Biol Chem 2004; 279 (17) 18063-18072
  CrossrefPubMedGoogle Scholar
• 20 Herren T, Burke TA, Das R, Plow EF. Identification of histone H2B as a regulated plasminogen receptor. Biochemistry 2006; 45 (31) 9463-9474
  CrossrefPubMedGoogle Scholar
• 21 Lacroix R, Sabatier F, Mialhe A , et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 2007; 110 (7) 2432-2439
  CrossrefPubMedGoogle Scholar
• 22 Toledo A, Coleman JL, Kuhlow CJ, Crowley JT, Benach JL. The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles. Infect Immun 2012; 80 (1) 359-368
  CrossrefPubMedGoogle Scholar
• 23 Kwaan HC, Rego EM. Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Semin Thromb Hemost 2010; 36 (8) 917-924
  Article in Thieme ConnectPubMedGoogle Scholar
• 24 Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol 2009; 22 (1) 153-163
  CrossrefPubMedGoogle Scholar
• 25 Angelucci A, D'Ascenzo S, Festuccia C , et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis 2000; 18 (2) 163-170
  CrossrefPubMedGoogle Scholar
• 26 Dolo V, D'Ascenzo S, Violini S , et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 1999; 17 (2) 131-140
  CrossrefPubMedGoogle Scholar
• 27 Ginestra A, Miceli D, Dolo V, Romano FM, Vittorelli ML. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 1999; 19 (4C) 3439-3445
  PubMedGoogle Scholar
• 28 Ginestra A, Monea S, Seghezzi G , et al. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem 1997; 272 (27) 17216-17222
  CrossrefPubMedGoogle Scholar
• 29 Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004; 64 (19) 7045-7049
  CrossrefPubMedGoogle Scholar
• 30 Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 2002; 106 (18) 2372-2378
  CrossrefPubMedGoogle Scholar
• 31 Lacroix R, Plawinski L, Robert S , et al. Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 2012; 97 (12) 1864-1872
  CrossrefPubMedGoogle Scholar
• 32 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256 (13) 7035-7041
  PubMedGoogle Scholar
• 33 Pennica D, Holmes WE, Kohr WJ , et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301 (5897) 214-221
  CrossrefPubMedGoogle Scholar
• 34 Rijken DC, Hoylaerts M, Collen D. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 1982; 257 (6) 2920-2925
  PubMedGoogle Scholar
• 35 Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol 2005; 129 (3) 307-321
  CrossrefPubMedGoogle Scholar
• 36 Millimaggi D, Festuccia C, Angelucci A , et al. Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells. Int J Oncol 2006; 28 (4) 909-914
  PubMedGoogle Scholar
• 37 Dejouvencel T, Doeuvre L, Lacroix R , et al. Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood 2010; 115 (10) 2048-2056
  CrossrefPubMedGoogle Scholar
• 38 Leroyer AS, Isobe H, Lesèche G , et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49 (7) 772-777
  CrossrefPubMedGoogle Scholar
• 39 Guller S, Tang Z, Ma YY, Di Santo S, Sager R, Schneider H. Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta 2011; 32 (1) 63-69
  CrossrefPubMedGoogle Scholar
• 40 Ramacciotti E, Hawley AE, Wrobleski SK , et al. Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010; 125 (6) e269-e274
  CrossrefPubMedGoogle Scholar
• 41 Ellis V, Murphy G. Cellular strategies for proteolytic targeting during migration and invasion. FEBS Lett 2001; 506 (1) 1-5
  CrossrefPubMedGoogle Scholar
• 42 Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL. The cell biology of the plasminogen system. FASEB J 1995; 9 (10) 939-945
  CrossrefPubMedGoogle Scholar
• 43 Lijnen HR. Elements of the fibrinolytic system. Ann N Y Acad Sci 2001; 936: 226-236
  CrossrefPubMedGoogle Scholar
• 44 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92 (8) 827-839
  CrossrefPubMedGoogle Scholar
• 45 Zucker S, Wieman JM, Lysik RM, Wilkie DP, Ramamurthy N, Lane B. Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles. Biochim Biophys Acta 1987; 924 (1) 225-237
  CrossrefPubMedGoogle Scholar
• 46 Dolo V, Ginestra A, Ghersi G, Nagase H, Vittorelli ML. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol 1994; 26 (2) 173-180
  PubMedGoogle Scholar
• 47 Dolo V, Ginestra A, Cassarà D , et al. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 1998; 58 (19) 4468-4474
  PubMedGoogle Scholar
• 48 Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002; 160 (2) 673-680
  CrossrefPubMedGoogle Scholar
• 49 Lozito TP, Tuan RS. Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol 2012; 227 (2) 534-549
  CrossrefPubMedGoogle Scholar
• 50 Aoki N, Jin-no S, Nakagawa Y , et al. Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 2007; 148 (8) 3850-3862
  CrossrefPubMedGoogle Scholar
• 51 Maeda S, Dean DD, Gay I, Schwartz Z, Boyan BD. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. J Bone Miner Res 2001; 16 (7) 1281-1290
  CrossrefPubMedGoogle Scholar
• 52 Martínez de Lizarrondo S, Roncal C, Calvayrac O , et al. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo. Arterioscler Thromb Vasc Biol 2012; 32 (6) 1477-1487
  CrossrefPubMedGoogle Scholar
• 53 Lacroix R, Dignat-George F. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res 2012; 129 (Suppl. 02) S27-S29
  CrossrefPubMedGoogle Scholar
• 54 Rossignol P, Luttun A, Martin-Ventura JL , et al. Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost 2006; 4 (3) 664-670
  CrossrefPubMedGoogle Scholar
• 55 Meilhac O, Ho-Tin-Noé B, Houard X, Philippe M, Michel JB, Anglés-Cano E. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J 2003; 17 (10) 1301-1303
  CrossrefPubMedGoogle Scholar
• 56 Michel JB. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003; 23 (12) 2146-2154
  CrossrefPubMedGoogle Scholar
• 57 Rossignol P, Ho-Tin-Noé B, Vranckx R , et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J Biol Chem 2004; 279 (11) 10346-10356
  CrossrefPubMedGoogle Scholar
• 58 Doeuvre L, Plawinski L, Goux D, Vivien D, Anglés-Cano E. Plasmin on adherent cells: from microvesiculation to apoptosis. Biochem J 2010; 432 (2) 365-373
  CrossrefPubMedGoogle Scholar
• 59 Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem 2002; 277 (37) 33564-33570
  CrossrefPubMedGoogle Scholar
• 60 Aoki N, Yokoyama R, Asai N , et al. Adipocyte-derived microvesicles are associated with multiple angiogenic factors and induce angiogenesis in vivo and in vitro. Endocrinology 2010; 151 (6) 2567-2576
  CrossrefPubMedGoogle Scholar
• 61 McCready J, Sims JD, Chan D, Jay DG. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 2010; 10: 294
  CrossrefPubMedGoogle Scholar
• 62 Jung T, Castellana D, Klingbeil P , et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009; 11 (10) 1093-1105
  CrossrefPubMedGoogle Scholar